Stenocare

1.44 DKK

+2.13 %

Less than 1K followers

STENO

First North Denmark

Biotechnology & Pharmaceuticals

Health Care

Overview

Financials & Estimates

Ownership

Investor consensus

+2.13 %

-2.70 %

-2.70 %

-5.26 %

+114.93 %

+203.80 %

-70.25 %

-85.28 %

-89.45 %

Stenocare is a Danish supplier of medical cannabis. Stenocare is the first player to have started sale of medical cannabis-based oils in Denmark. The company is now looking towards further European markets for its products. Stenocare is based in Randers, Denmark.

Market cap

62.5M DKK

Turnover

75.87K DKK

Revenue

4.76M

EBIT %

-695.17 %

P/E

-

Dividend yield-%

-

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

26/2

2026

Annual report '25

All

Press releases

3rd party

ShowingAll content types

Press release1/28/2026, 8:28 AM

Analyst Group: Analyst Group Comment on STENOCAREs partnership with WEECO and Launch of a New Astrum Oil Product in Germany

Press release1/27/2026, 3:27 PM

STENOCARE: Stenocare Kicks Off Strategic Partnership with WEECO to Launch New Astrum Oil Product in Germany

Regulatory press release12/30/2025, 10:19 AM

Trading in STENOCARE shares by closely related party to board member

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Press release11/21/2025, 5:41 AM

BioStock: Stenocare förvärvar Canngros

Press release11/21/2025, 5:41 AM

BioStock: Stenocare acquires Canngros

Press release11/19/2025, 6:56 PM

STENOCARE share analyst's comments on the CannGros acquisition

Press release11/18/2025, 11:18 AM

Analyst Group: Analyst Group Comment on STENOCAREs acquisition of CannGros ApS

Regulatory press release11/18/2025, 8:59 AM

STENOCARE: Correction of total shares issued and total nominal share capital:

Regulatory press release11/17/2025, 4:56 PM

STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal

Regulatory press release11/17/2025, 4:01 PM

STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal

Press release10/24/2025, 12:31 PM

Analyst Group: Equity Research Report on STENOCARE - Transforms to a Profitable Growth Company

Press release10/22/2025, 12:54 PM

Analyst Group: Analyst Group Comment on STENOCARE’s Q3-report 2025

Regulatory press release10/22/2025, 6:00 AM

STENOCARE: Interim report third quarter 2025

Press release8/29/2025, 1:10 PM

Analyst Group: Equity Research Report on STENOCARE - Capitalizes on STENOCARE 3.0

Regulatory press release8/27/2025, 7:30 PM

Trading in STENOCARE shares by closely related party to board member

Press release8/21/2025, 10:50 AM

Analyst Group: Analyst Group Comment on STENOCARE’s Q2-report 2025

Regulatory press release8/21/2025, 6:00 AM

STENOCARE: Interim report second quarter 2025

Third party research5/19/2025, 8:05 AM

STENOCARE: Time to Capitalize on STENOCARE 3.0 - Analyst Group

STENOCARE A/S (“STENOCARE” or the “Company”) is a medical cannabis trading company with products approved and available for patients in six countries. The Company has recently launched a premium product, Astrum oil, which Analyst Group sees as an important...

Press release5/19/2025, 8:02 AM

Analyst Group: Equity Research Report on STENOCARE - Time to Capitalize on STENOCARE 3.0

Regulatory press release5/15/2025, 9:36 AM

Communiqué from the Annual General Meeting of STENOCARE

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.